Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114835749B details a mild Grignard-based route for DuPhos and BPE ligands, eliminating hazardous P-H intermediates for safer large-scale manufacturing.
Patent CN106279274B enables efficient beta-carbonyl phosphonate synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Novel salt-based purification method for Rebamipide achieving >99.8% purity. Reduces impurities significantly using simple solvents. Ideal for pharmaceutical manufacturing.
Patent CN118666669A reveals efficient asymmetric synthesis for sitafloxacin intermediates. Achieve high purity and scalable production with reduced operational complexity.
Novel 8-step synthesis of 5-fluoro-3-methylisobenzofuranone from phthalimide. High yield, low cost route for Laratinib intermediate suitable for commercial scale-up.
Patent CN102627684A reveals chromium-free oxidation. Enhances supply chain reliability and reduces environmental waste for pharmaceutical intermediates.
Patent CN108129357B details a novel one-pot method for producing high-purity anamorelin intermediates, offering significant safety and cost advantages for pharmaceutical supply chains.
Patent CN115838330B reveals a visible-light method for dicarboxylic acids using CO2. This breakthrough offers cost reduction and supply chain reliability for fine chemical manufacturing.
Novel taurine-catalyzed synthesis offers green efficiency. Reliable supply chain for pharmaceutical intermediates with reduced environmental impact and cost.
Patent CN115369430A reveals a green electrochemical route for C-3 aminomethylation. Achieves high yields without external oxidants, offering cost-effective manufacturing for pharma intermediates.
Patent CN106146316A reveals high-selectivity boron catalysis for 1,2-diaryl ethylenediamines. Enables cost reduction and supply chain reliability in pharmaceutical intermediates manufacturing.
Discover advanced benzomorpholone derivatives for oncology. Our patented synthesis offers cost-effective, scalable manufacturing for high-purity BET inhibitor intermediates.
Patent CN113735770B details a novel Rh-catalyzed route to 1-aminoisoquinolines using vinylene carbonate, offering safer reagents and improved atom economy for industrial API manufacturing.
Patent CN109942514A reveals efficient Ir-catalyzed route for Atazanavir intermediate. Enables cost reduction in API manufacturing and reliable supply chain continuity.
Patent CN114133323B reveals a safe TMSCN-based route for morphine precursors, offering significant yield improvements and cost reduction in API manufacturing.
Patent CN111116339B reveals a novel acidic boron-complex route for curcumin. Achieve 90% yields with reduced waste. Ideal for reliable curcumin supplier partnerships.
Patent CN113045501B details a novel low-cost synthesis for 7-methyl-2-n-propyl-3H-benzimidazole-5-aldehyde, offering significant supply chain and purity advantages.
Advanced preparation method for Oxitinib Mesylate intermediates via anhydrous catalysis. Delivers high purity, reduced genotoxic impurities, and scalable manufacturing for global supply chains.
Discover the industrial production method for nitrogen-containing heterocyclic compounds with excellent FLT3 inhibitory activity. Optimized for high purity and scalable manufacturing.
Patent CN113105301A details a novel ortho-carborane copper complex for mild Glaser coupling, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.